..., but the evolving anticlonal options have changed the field landscape. A major barrier in clinical practice remains the lack of established eligibility criteria to determine candidates for transplantation and when they should be considered for renal transplants. Over the last 2 decades, few retrospective studies...

.... 288: 1313-1317 (1973). 7 G arovoy, M. R.; Phillips, S. M.; C arpenter, C. B., and M errill, J. P.: Anti­ body modulation of cellular reactivity post renal transplantation. Tranplantn Proc. 5: 129-132 (1973). 8 H uber, H.; Pastner, D.; D itterich, P., and Braunsteiner, H.: In vitro reac­ tivity...